Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index

Background Reduction in glucocorticoid exposure is the primary benefit of new biologic treatments in severe asthma, but there is currently no evidence that reduction in glucocorticoid exposure corresponds to a proportionate reduction in associated toxicity. Objectives To use the validated Glucocorti...

Full description

Bibliographic Details
Main Authors: Butler, C.A (Author), Dunn, L. (Author), Heaney, L.G (Author), Honeyford, K. (Author), Jane McDowell, P. (Author), Jayne Logan, R. (Author), McGarvey, L.P.A (Author), Stone, J.H (Author), Zhang, Y. (Author)
Format: Article
Language:English
Published: European Respiratory Society 2022
Subjects:
Online Access:View Fulltext in Publisher